| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 02/14/2008 | WO2008019214A1 Modified erythropoietin |
| 02/14/2008 | WO2008019143A2 Use of exendins and glp-i receptor agonists for altering lipoprotein particle size and subclass composition |
| 02/14/2008 | WO2008019062A2 Polypeptide derivatives of parathyroid hormone (pth) |
| 02/14/2008 | WO2008019036A2 Long half-life recombinant butyrylcholinesterase |
| 02/14/2008 | WO2008019018A2 Bioactive molecular matrix and methods of use in the treatment of disease |
| 02/14/2008 | WO2008018854A2 Bactiophage lysins for bacillus anthracis |
| 02/14/2008 | WO2008018792A2 Cyclic angiotensin analogs |
| 02/14/2008 | WO2008018600A1 THERAPEUTIC AGENT FOR ACCELERATION OF SPINAL NERVE REPAIR COMPRISING GHRELIN, DERIVATIVE THEREOF OR SUBSTANCE CAPABLE OF ACTING ON GHS-R1a AS ACTIVE INGREDIENT |
| 02/14/2008 | WO2008018597A1 Therapeutic agent for acceleration of spinal nerve repair comprising desacyl ghrelin or derivative thereof as active ingredient |
| 02/14/2008 | WO2008018555A1 HBsAg PARTICLE HAVING LOW ANTIGENICITY AND METHOD FOR PRODUCTION THEREOF |
| 02/14/2008 | WO2008018488A1 Antibacterial agent |
| 02/14/2008 | WO2008018111A2 Composition containing cranberry (vaccinium macrocarpon) and lactoferrin for the prevention and treatment of urinary tract infections |
| 02/14/2008 | WO2008018103A1 Product, suitable to be given to the human body for its protective effects and health benefits, based on cow buffalo's milk self-enriched with lactoferrin, or pure lactoferrin, obtained through membrane separative processes |
| 02/14/2008 | WO2008018084A2 Peptides derived from plasminogen activator inhibitor for preventing neuronal damage |
| 02/14/2008 | WO2008017955A1 Novel phosphopeptides and uses thereof in preventing kidney stone formation |
| 02/14/2008 | WO2008017894A1 Peptide for treatment of asthma |
| 02/14/2008 | WO2008017734A1 Polymyxin derivatives and uses thereof |
| 02/14/2008 | WO2008017415A1 Casein complexes |
| 02/14/2008 | WO2008017372A1 Peptides having pharmacological activity for treating disorders associated with altered cell migration, such as cancer |
| 02/14/2008 | WO2008017264A1 Pharmaceutical composition comprising methyl donors or methyl donor enhancers and anti-viral compounds |
| 02/14/2008 | WO2008017126A1 Treatment of pulmonary disease conditions |
| 02/14/2008 | WO2008017125A1 Targeted polylysine dendrimer therapeutic agent |
| 02/14/2008 | WO2008017123A1 Methods for modulating apoptosis in platelets |
| 02/14/2008 | WO2008017121A1 Methods for modulating apoptosis in platelets |
| 02/14/2008 | WO2008001175A3 Dipeptide compounds containing d-histidine |
| 02/14/2008 | WO2007149382A3 Therapeutic compositions and methods useful in treating hepatitis |
| 02/14/2008 | WO2007146897A3 The treatment of xerostomia |
| 02/14/2008 | WO2007146038A9 Albumin fusion proteins |
| 02/14/2008 | WO2007144554A3 Gnrh (gonadotropin-releasing hormone) peptide variants |
| 02/14/2008 | WO2007143689A3 Compositions and methods for modulating vascular development |
| 02/14/2008 | WO2007143174A3 Combination therapy method and formulation |
| 02/14/2008 | WO2007137149A3 Use of cathepsin k antagonists in bone production |
| 02/14/2008 | WO2007134147A3 Method of vaccinating subjects receiving immune modulating therapy |
| 02/14/2008 | WO2007118680A3 Remedies for ischemia |
| 02/14/2008 | WO2007113531A3 Topical drug delivery |
| 02/14/2008 | WO2007108990A3 Use of ghrelin splice variant for treating cachexia and/or anorexia and/or anorexia-cachexia and/or malnutrition and/or lipodystrophy and/or muscle wasting and/or appetite stimulation |
| 02/14/2008 | WO2007107981A9 Methods, compositions and devices for maintaining chemical balance of chlorinated water |
| 02/14/2008 | WO2007106893A3 Use of thrombin mutants to inhibit the anticoagulation effect of thrombin inhibitors |
| 02/14/2008 | WO2007092582A3 Neutralization of bacterial spores |
| 02/14/2008 | WO2007081824A3 Fibrillation resistant proteins |
| 02/14/2008 | WO2007081720A3 Microrna-based methods and compositions for the diagnosis, prognosis and treatment of lung cancer |
| 02/14/2008 | WO2007080194A3 Use of tpp ii inhibitors in combination with gamma-irradiation for the treatment of cancer |
| 02/14/2008 | WO2007079096A3 Protease inhibition |
| 02/14/2008 | WO2007076537A3 Methods and compositions related to mutant kunitz domain i of tfpi-2 |
| 02/14/2008 | WO2007067976A3 Method of using il6 antagonists with proteasome inhibitors |
| 02/14/2008 | WO2007052173A3 Activity of thap-family chemokine-binding domains |
| 02/14/2008 | WO2007010283A8 Serine beta-lactamase-like / d-ala carboxypeptidase-like protein |
| 02/14/2008 | US20080040827 Secreted Insecticidal Protein and Gene Compositions from Bacillus Thuringiensis and Uses Therefor |
| 02/14/2008 | US20080039611 Cross-linked glycopeptide-cephalosporin antibiotics |
| 02/14/2008 | US20080039449 [1,4]benzodiazepine derivatives, used for treating osteoarthritis, pancreatitis, glomerulonephritis, rheumatoid arthritis, inflammatory bowel disease, Crohn's disease, psoriasis, graft vs host disease, leukemia, septic shock, multiple sclerosis, and inflammatory bowel disease |
| 02/14/2008 | US20080039419 Integrin-linked kinase and its uses |
| 02/14/2008 | US20080039412 Short interfering RNA sequences for use in therapeutic, veterinary, agricultural, diagnostic, target validation, and genomic discovery applications |
| 02/14/2008 | US20080039410 Inositol 1,4,5-Trisphosphate Receptor Mutants and Uses Thereof |
| 02/14/2008 | US20080039404 Bifunctional analgesic compounds for opioid receptor agonists and neurokinin-1 receptor antagonists |
| 02/14/2008 | US20080039403 Exposing the cancer cell to a peptide has antiestrotrophic activity; inhibit estrogen receptor dependent cell proliferation; breast cancer |
| 02/14/2008 | US20080039402 Peptides and Peptidomimetics Binding to Cd23 |
| 02/14/2008 | US20080039401 For allergy such as asthma; modulating interleukin (IL)-9 expression |
| 02/14/2008 | US20080039400 Treatment and prevention of inflammatory bowel diseases |
| 02/14/2008 | US20080039399 Methods and systems for neural maintenance and regeneration |
| 02/14/2008 | US20080039398 Formulations and methods for treating dry eye |
| 02/14/2008 | US20080039397 Polynucleotide encoding a tropoelastin polypeptide; expression products and hybrid molecules of the derivatives and variants |
| 02/14/2008 | US20080039396 Freeze drying an aliquot of an aqueous solution blood factor such as antihemophilic factor or blood-coagulation factor IX in the presence of trehalose stabilizer wherein the aliquot is free of albumin; hemophilia treatment |
| 02/14/2008 | US20080039395 Methods for treating septic shock |
| 02/14/2008 | US20080039394 Dendroaspis natriuretic peptide |
| 02/14/2008 | US20080039393 Metal-binding therapeutic peptides |
| 02/14/2008 | US20080039391 such as dabigatran etexilate; immobilized patients, congenital heart disease, shunt or catheter thrombosis, pulmonary embolism, stroke in pregnant women |
| 02/14/2008 | US20080039390 Use of the insulin-like-growth factor I splice variant MGF for the prevention of myocardial damage |
| 02/14/2008 | US20080039389 Dosing regimens for neural stem cell proliferating agents and differentiating agents for the treatment of neurological disorders |
| 02/14/2008 | US20080039388 Derived from the chain of the (B)beta(15-42)-fibrin fragment substituted by genetically encoded or not genetically encoded amino acids or peptidomimetics; cysteine modified by succinimido-polyoxyethylene glycol; antiinflammatory agents; endothelium stabilizers |
| 02/14/2008 | US20080039387 Specific peptide conjugates with high modulating effect on melanocortin receptors; anorectic drug or energy expenditure regulating drug |
| 02/14/2008 | US20080039385 Neublastin Variants |
| 02/14/2008 | US20080039384 Antiangiogenic Peptides |
| 02/14/2008 | US20080039383 Methods and compositions for inhibiting ER-stress induced cholesterol/triglyceride accumulation |
| 02/14/2008 | US20080039382 Compositions related to pleiotrophin methods and uses thereof |
| 02/14/2008 | US20080039381 Lactalbumin for Inhibiting Angiogenesis |
| 02/14/2008 | US20080039380 Agent for Prophylactic and/or Therapeutic Treatment of Retinopathy |
| 02/14/2008 | US20080039379 Compositions Comprising Gastrin Compounds and Their Use in Diabetes |
| 02/14/2008 | US20080039378 Cyclosporin compositions |
| 02/14/2008 | US20080039377 Composition Comprising a Jnk Inhibitor and Cyclosporin |
| 02/14/2008 | US20080039376 Use of Cyclic Anabaenopeptin-type Peptides for the Treatment of a Condition Wherein Inhibition of Carboxypeptidase U is Beneficial, Novel Anabaenopeptin Derivatives and Intermediates Thereof |
| 02/14/2008 | US20080039375 Fused heterocycloalkyl ring substituted quinoxaline compounds, for example; interfere with the life cycle of the hepatitis C virus and are useful as antiviral agents |
| 02/14/2008 | US20080039374 Cross-lined glycopeptide-cephalosporin antibiotics |
| 02/14/2008 | US20080039373 Pegylated Factor VII Glycoforms |
| 02/14/2008 | US20080039372 Human chorionic gonadotropin antagonists and methods to prevent ovarian hyperstimulation |
| 02/14/2008 | US20080039371 Erythropoietin Liquid Formulation |
| 02/14/2008 | US20080039370 Stable Oxidation Resistant Powdered Hemoglobin, Methods of Preparing Same, and Uses Thereof |
| 02/14/2008 | US20080039369 Microsphere-based composition for preventing and/or reversing new-onset autoimmune diabetes |
| 02/14/2008 | US20080039368 Rapid acting and long acting insulin combination formulations |
| 02/14/2008 | US20080039367 Medicinal Composition Containing Diabeted Remedy |
| 02/14/2008 | US20080039366 Administering insulin, sodium citrate and phospholipid to respiratory tract |
| 02/14/2008 | US20080039365 Rapid Acting and Long Acting Insulin Combination Formulations |
| 02/14/2008 | US20080039363 administering angiotensinogen; pluripotent stem cell transplantation; for supporting bone marrow transplantation, and promoting megakaryocyte production and mobilization and platelet production; improved leukocyte production |
| 02/14/2008 | US20080039362 Combination drug therapy for reducing scar tissue formation |
| 02/14/2008 | US20080038809 ISOLATED LECTIN POLYPEPTIDES CONSISTING OF TRUNCATED MAMMALIAN UDP-GalNAc:POLYPEPTIDE N- ACETYLGALACTOSAMINYLTRANSFERASES |
| 02/14/2008 | US20080038731 Diagnostics and therapeutic uses of topors |
| 02/14/2008 | US20080038361 Water-Soluble Nanoparticles Stabilized with Multi-Functional Group Ligands and Method of Preparation Thereof |
| 02/14/2008 | US20080038357 Inhalation Powder Containing the CGRP antagonist BIBN4096 and Process for the Preparation Thereof |
| 02/14/2008 | US20080038354 Polymeric matrices for the controlled release of a hydrophilic bioactive agent; hydrophilic drug delivery; side effect reduction |
| 02/14/2008 | US20080038353 Polymer Based Nano-Carriers For The Solubilization And Delivery Of Hydrophobic Drugs |
| 02/14/2008 | US20080038351 Flowable carrier matrix |